Actively Recruiting

Age: 0 - 100Years
All Genders
NCT00669266

Adrenal Tumors - Pathogenesis and Therapy

Led by University of Wuerzburg · Updated on 2026-05-07

500

Participants Needed

1

Research Sites

1578 weeks

Total Duration

On this page

Sponsors

U

University of Wuerzburg

Lead Sponsor

D

Deutsche Krebshilfe e.V., Bonn (Germany)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.

CONDITIONS

Official Title

Adrenal Tumors - Pathogenesis and Therapy

Who Can Participate

Age: 0 - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have an adrenal tumor detected by imaging
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Wuerzburg

Würzburg, Germany, 97080

Actively Recruiting

Loading map...

Research Team

M

Martin Fassnacht, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here